• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.05% Nasdaq Down0.18%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    42.65 Down 0.26(0.61%) 4:00PM EDT
    |After Hours : 44.55 Up 1.90 (4.45%) 7:52PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue -   -   -   19,769  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   19,769  
    Operating Expenses
    Research Development21,809  24,388  18,719  16,575  
    Selling General and Administrative8,939  11,456  6,603  5,482  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (30,748) (35,844) (25,322) (2,288)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,433  1,409  1,335  1,096  
    Earnings Before Interest And Taxes(29,315)(34,435)(23,987)(1,192)
    Interest Expense -   -   -   -  
    Income Before Tax(29,315)(34,435)(23,987)(1,192)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(29,315)(34,435)(23,987)(1,192)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (29,315) (34,435) (23,987) (1,192)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (29,315) (34,435) (23,987) (1,192)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.